<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20240428041219&amp;utm_medium=rss&amp;fc=20230708114047&amp;v=2.18.0.post9+e462414&amp;utm_campaign=pubmed-2&amp;utm_source=Chrome&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20240428041219&amp;utm_medium=rss&amp;fc=20230708114047&amp;v=2.18.0.post9+e462414&amp;utm_campaign=pubmed-2&amp;utm_source=Chrome&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Sun, 28 Apr 2024 08:12:23 +0000</lastbuilddate>
<pubDate>Sat, 27 Apr 2024 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>Where are cardiology's nuts and bolts to be found?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38676374/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240428041219&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Apr 27:ehae209. doi: 10.1093/eurheartj/ehae209. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38676374/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240428041219&v=2.18.0.post9+e462414">38676374</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae209>10.1093/eurheartj/ehae209</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38676374</guid>
<pubDate>Sat, 27 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Peter Lanzer</dc:creator>
<dc:date>2024-04-27</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Where are cardiology's nuts and bolts to be found?</dc:title>
<dc:identifier>pmid:38676374</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae209</dc:identifier>
</item>
<item>
<title>Positive selection CRISPR screens reveal a druggable pocket in an oligosaccharyltransferase required for inflammatory signaling to NF-κB</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38670073/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240428041219&amp;v=2.18.0.post9+e462414
      <description>Nuclear factor κB (NF-κB) plays roles in various diseases. Many inflammatory signals, such as circulating lipopolysaccharides (LPSs), activate NF-κB via specific receptors. Using whole-genome CRISPR-Cas9 screens of LPS-treated cells that express an NF-κB-driven suicide gene, we discovered that the LPS receptor Toll-like receptor 4 (TLR4) is specifically dependent on the oligosaccharyltransferase complex OST-A for N-glycosylation and cell-surface localization. The tool compound NGI-1 inhibits OST...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Apr 25;187(9):2209-2223.e16. doi: 10.1016/j.cell.2024.03.022.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Nuclear factor κB (NF-κB) plays roles in various diseases. Many inflammatory signals, such as circulating lipopolysaccharides (LPSs), activate NF-κB via specific receptors. Using whole-genome CRISPR-Cas9 screens of LPS-treated cells that express an NF-κB-driven suicide gene, we discovered that the LPS receptor Toll-like receptor 4 (TLR4) is specifically dependent on the oligosaccharyltransferase complex OST-A for N-glycosylation and cell-surface localization. The tool compound NGI-1 inhibits OST complexes in vivo, but the underlying molecular mechanism remained unknown. We did a CRISPR base-editor screen for NGI-1-resistant variants of STT3A, the catalytic subunit of OST-A. These variants, in conjunction with cryoelectron microscopy studies, revealed that NGI-1 binds the catalytic site of STT3A, where it traps a molecule of the donor substrate dolichyl-PP-GlcNAc<sub>2</sub>-Man<sub>9</sub>-Glc<sub>3</sub>, suggesting an uncompetitive inhibition mechanism. Our results provide a rationale for and an initial step toward the development of STT3A-specific inhibitors and illustrate the power of contemporaneous base-editor and structural studies to define drug mechanism of action.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38670073/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240428041219&v=2.18.0.post9+e462414">38670073</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.03.022>10.1016/j.cell.2024.03.022</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38670073</guid>
<pubDate>Fri, 26 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Benjamin L Lampson</dc:creator>
<dc:creator>Ana S Ramίrez</dc:creator>
<dc:creator>Marta Baro</dc:creator>
<dc:creator>Lixia He</dc:creator>
<dc:creator>Mudra Hegde</dc:creator>
<dc:creator>Vidyasagar Koduri</dc:creator>
<dc:creator>Jamie L Pfaff</dc:creator>
<dc:creator>Ruth E Hanna</dc:creator>
<dc:creator>Julia Kowal</dc:creator>
<dc:creator>Nitin H Shirole</dc:creator>
<dc:creator>Yanfeng He</dc:creator>
<dc:creator>John G Doench</dc:creator>
<dc:creator>Joseph N Contessa</dc:creator>
<dc:creator>Kaspar P Locher</dc:creator>
<dc:creator>William G Kaelin</dc:creator>
<dc:date>2024-04-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Positive selection CRISPR screens reveal a druggable pocket in an oligosaccharyltransferase required for inflammatory signaling to NF-κB</dc:title>
<dc:identifier>pmid:38670073</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.03.022</dc:identifier>
</item>
<item>
<title>Functional sensory circuits built from neurons of two species</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38670072/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240428041219&amp;v=2.18.0.post9+e462414
      <description>A central question for regenerative neuroscience is whether synthetic neural circuits, such as those built from two species, can function in an intact brain. Here, we apply blastocyst complementation to selectively build and test interspecies neural circuits. Despite approximately 10-20 million years of evolution, and prominent species differences in brain size, rat pluripotent stem cells injected into mouse blastocysts develop and persist throughout the mouse brain. Unexpectedly, the mouse...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Apr 25;187(9):2143-2157.e15. doi: 10.1016/j.cell.2024.03.042.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">A central question for regenerative neuroscience is whether synthetic neural circuits, such as those built from two species, can function in an intact brain. Here, we apply blastocyst complementation to selectively build and test interspecies neural circuits. Despite approximately 10-20 million years of evolution, and prominent species differences in brain size, rat pluripotent stem cells injected into mouse blastocysts develop and persist throughout the mouse brain. Unexpectedly, the mouse niche reprograms the birth dates of rat neurons in the cortex and hippocampus, supporting rat-mouse synaptic activity. When mouse olfactory neurons are genetically silenced or killed, rat neurons restore information flow to odor processing circuits. Moreover, they rescue the primal behavior of food seeking, although less well than mouse neurons. By revealing that a mouse can sense the world using neurons from another species, we establish neural blastocyst complementation as a powerful tool to identify conserved mechanisms of brain development, plasticity, and repair.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38670072/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240428041219&v=2.18.0.post9+e462414">38670072</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.03.042>10.1016/j.cell.2024.03.042</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38670072</guid>
<pubDate>Fri, 26 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Benjamin T Throesch</dc:creator>
<dc:creator>Muhammad Khadeesh Bin Imtiaz</dc:creator>
<dc:creator>Rodrigo Muñoz-Castañeda</dc:creator>
<dc:creator>Masahiro Sakurai</dc:creator>
<dc:creator>Andrea L Hartzell</dc:creator>
<dc:creator>Kiely N James</dc:creator>
<dc:creator>Alberto R Rodriguez</dc:creator>
<dc:creator>Greg Martin</dc:creator>
<dc:creator>Giordano Lippi</dc:creator>
<dc:creator>Sergey Kupriyanov</dc:creator>
<dc:creator>Zhuhao Wu</dc:creator>
<dc:creator>Pavel Osten</dc:creator>
<dc:creator>Juan Carlos Izpisua Belmonte</dc:creator>
<dc:creator>Jun Wu</dc:creator>
<dc:creator>Kristin K Baldwin</dc:creator>
<dc:date>2024-04-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Functional sensory circuits built from neurons of two species</dc:title>
<dc:identifier>pmid:38670072</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.03.042</dc:identifier>
</item>
<item>
<title>Generation of rat forebrain tissues in mice</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38670071/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240428041219&amp;v=2.18.0.post9+e462414
      <description>Interspecies blastocyst complementation (IBC) provides a unique platform to study development and holds the potential to overcome worldwide organ shortages. Despite recent successes, brain tissue has not been achieved through IBC. Here, we developed an optimized IBC strategy based on C-CRISPR, which facilitated rapid screening of candidate genes and identified that Hesx1 deficiency supported the generation of rat forebrain tissue in mice via IBC. Xenogeneic rat forebrain tissues in adult mice...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Apr 25;187(9):2129-2142.e17. doi: 10.1016/j.cell.2024.03.017.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Interspecies blastocyst complementation (IBC) provides a unique platform to study development and holds the potential to overcome worldwide organ shortages. Despite recent successes, brain tissue has not been achieved through IBC. Here, we developed an optimized IBC strategy based on C-CRISPR, which facilitated rapid screening of candidate genes and identified that Hesx1 deficiency supported the generation of rat forebrain tissue in mice via IBC. Xenogeneic rat forebrain tissues in adult mice were structurally and functionally intact. Cross-species comparative analyses revealed that rat forebrain tissues developed at the same pace as the mouse host but maintained rat-like transcriptome profiles. The chimeric rate of rat cells gradually decreased as development progressed, suggesting xenogeneic barriers during mid-to-late pre-natal development. Interspecies forebrain complementation opens the door for studying evolutionarily conserved and divergent mechanisms underlying brain development and cognitive function. The C-CRISPR-based IBC strategy holds great potential to broaden the study and application of interspecies organogenesis.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38670071/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240428041219&v=2.18.0.post9+e462414">38670071</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.03.017>10.1016/j.cell.2024.03.017</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38670071</guid>
<pubDate>Fri, 26 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Jia Huang</dc:creator>
<dc:creator>Bingbing He</dc:creator>
<dc:creator>Xiali Yang</dc:creator>
<dc:creator>Xin Long</dc:creator>
<dc:creator>Yinghui Wei</dc:creator>
<dc:creator>Leijie Li</dc:creator>
<dc:creator>Min Tang</dc:creator>
<dc:creator>Yanxia Gao</dc:creator>
<dc:creator>Yuan Fang</dc:creator>
<dc:creator>Wenqin Ying</dc:creator>
<dc:creator>Zikang Wang</dc:creator>
<dc:creator>Chao Li</dc:creator>
<dc:creator>Yingsi Zhou</dc:creator>
<dc:creator>Shuaishuai Li</dc:creator>
<dc:creator>Linyu Shi</dc:creator>
<dc:creator>Seungwon Choi</dc:creator>
<dc:creator>Haibo Zhou</dc:creator>
<dc:creator>Fan Guo</dc:creator>
<dc:creator>Hui Yang</dc:creator>
<dc:creator>Jun Wu</dc:creator>
<dc:date>2024-04-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Generation of rat forebrain tissues in mice</dc:title>
<dc:identifier>pmid:38670071</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.03.017</dc:identifier>
</item>
<item>
<title>Mapping the pancancer metastasis tumor microbiome</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38670070/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240428041219&amp;v=2.18.0.post9+e462414
      <description>The landscape of the intratumoral microbiome in tumor metastases is largely unchartered. In this issue of Cell, Voest et al. profiled the tumor metastasis-associated microbiome in a pancancer cohort of 4,160 biopsies from 26 cancer types. This dataset offers a useful resource for understanding the role of the microbiome in metastatic cancers.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Apr 25;187(9):2126-2128. doi: 10.1016/j.cell.2024.03.040.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The landscape of the intratumoral microbiome in tumor metastases is largely unchartered. In this issue of Cell, Voest et al. profiled the tumor metastasis-associated microbiome in a pancancer cohort of 4,160 biopsies from 26 cancer types. This dataset offers a useful resource for understanding the role of the microbiome in metastatic cancers.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38670070/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240428041219&v=2.18.0.post9+e462414">38670070</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.03.040>10.1016/j.cell.2024.03.040</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38670070</guid>
<pubDate>Fri, 26 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Chi Chun Wong</dc:creator>
<dc:creator>Jun Yu</dc:creator>
<dc:date>2024-04-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Mapping the pancancer metastasis tumor microbiome</dc:title>
<dc:identifier>pmid:38670070</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.03.040</dc:identifier>
</item>
<item>
<title>A glycolytic metabolite that drives BRCA2 haploinsufficiency</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38670069/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240428041219&amp;v=2.18.0.post9+e462414
      <description>Many types of tumor cells alter metabolic pathways to meet their energy and biosynthetic demands for proliferation or stress adaptation. In this issue of Cell, Kong et al. find that the glycolytic metabolite methylglyoxal causes cancer-associated mutant single-base substitution features by inducing BRCA2 proteolysis, leading to functional haploinsufficiency of BRCA2.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Apr 25;187(9):2124-2126. doi: 10.1016/j.cell.2024.03.028.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Many types of tumor cells alter metabolic pathways to meet their energy and biosynthetic demands for proliferation or stress adaptation. In this issue of Cell, Kong et al. find that the glycolytic metabolite methylglyoxal causes cancer-associated mutant single-base substitution features by inducing BRCA2 proteolysis, leading to functional haploinsufficiency of BRCA2.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38670069/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240428041219&v=2.18.0.post9+e462414">38670069</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.03.028>10.1016/j.cell.2024.03.028</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38670069</guid>
<pubDate>Fri, 26 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Peng Jiang</dc:creator>
<dc:date>2024-04-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>A glycolytic metabolite that drives BRCA2 haploinsufficiency</dc:title>
<dc:identifier>pmid:38670069</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.03.028</dc:identifier>
</item>
<item>
<title>Many paths lead to immunology</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38670068/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240428041219&amp;v=2.18.0.post9+e462414
      <description>While some people pore over the textbook and train through the classics of the field, many scientists come to immunology when they discover it intersecting with their "first love" interests. Five of these "accidental immunologists" tell us how they found their way to a fascination with the immune system.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Apr 25;187(9):2117-2119. doi: 10.1016/j.cell.2024.03.033.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">While some people pore over the textbook and train through the classics of the field, many scientists come to immunology when they discover it intersecting with their "first love" interests. Five of these "accidental immunologists" tell us how they found their way to a fascination with the immune system.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38670068/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240428041219&v=2.18.0.post9+e462414">38670068</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.03.033>10.1016/j.cell.2024.03.033</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38670068</guid>
<pubDate>Fri, 26 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Ana J García-Sáez</dc:creator>
<dc:creator>Ana I Domingos</dc:creator>
<dc:creator>J Silvio Gutkind</dc:creator>
<dc:creator>Seema Mattoo</dc:creator>
<dc:creator>Peng Du</dc:creator>
<dc:date>2024-04-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Many paths lead to immunology</dc:title>
<dc:identifier>pmid:38670068</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.03.033</dc:identifier>
</item>
<item>
<title>The plant immune system: From discovery to deployment</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38670067/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240428041219&amp;v=2.18.0.post9+e462414
      <description>Plant diseases cause famines, drive human migration, and present challenges to agricultural sustainability as pathogen ranges shift under climate change. Plant breeders discovered Mendelian genetic loci conferring disease resistance to specific pathogen isolates over 100 years ago. Subsequent breeding for disease resistance underpins modern agriculture and, along with the emergence and focus on model plants for genetics and genomics research, has provided rich resources for molecular biological...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Apr 25;187(9):2095-2116. doi: 10.1016/j.cell.2024.03.045.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Plant diseases cause famines, drive human migration, and present challenges to agricultural sustainability as pathogen ranges shift under climate change. Plant breeders discovered Mendelian genetic loci conferring disease resistance to specific pathogen isolates over 100 years ago. Subsequent breeding for disease resistance underpins modern agriculture and, along with the emergence and focus on model plants for genetics and genomics research, has provided rich resources for molecular biological exploration over the last 50 years. These studies led to the identification of extracellular and intracellular receptors that convert recognition of extracellular microbe-encoded molecular patterns or intracellular pathogen-delivered virulence effectors into defense activation. These receptor systems, and downstream responses, define plant immune systems that have evolved since the migration of plants to land ∼500 million years ago. Our current understanding of plant immune systems provides the platform for development of rational resistance enhancement to control the many diseases that continue to plague crop production.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38670067/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240428041219&v=2.18.0.post9+e462414">38670067</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.03.045>10.1016/j.cell.2024.03.045</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38670067</guid>
<pubDate>Fri, 26 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Jonathan D G Jones</dc:creator>
<dc:creator>Brian J Staskawicz</dc:creator>
<dc:creator>Jeffery L Dangl</dc:creator>
<dc:date>2024-04-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>The plant immune system: From discovery to deployment</dc:title>
<dc:identifier>pmid:38670067</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.03.045</dc:identifier>
</item>
<item>
<title>Exploring new perspectives in immunology</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38670066/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240428041219&amp;v=2.18.0.post9+e462414
      <description>Several conceptual pillars form the foundation of modern immunology, including the clonal selection theory, antigen receptor diversity, immune memory, and innate control of adaptive immunity. However, some immunological phenomena cannot be explained by the current framework. Thus, we still do not know how to design vaccines that would provide long-lasting protective immunity against certain pathogens, why autoimmune responses target some antigens and not others, or why the immune response to...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Apr 25;187(9):2079-2094. doi: 10.1016/j.cell.2024.03.038.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Several conceptual pillars form the foundation of modern immunology, including the clonal selection theory, antigen receptor diversity, immune memory, and innate control of adaptive immunity. However, some immunological phenomena cannot be explained by the current framework. Thus, we still do not know how to design vaccines that would provide long-lasting protective immunity against certain pathogens, why autoimmune responses target some antigens and not others, or why the immune response to infection sometimes does more harm than good. Understanding some of these mysteries may require that we question existing assumptions to develop and test alternative explanations. Immunology is increasingly at a point when, once again, exploring new perspectives becomes a necessity.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38670066/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240428041219&v=2.18.0.post9+e462414">38670066</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.03.038>10.1016/j.cell.2024.03.038</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38670066</guid>
<pubDate>Fri, 26 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Ruslan Medzhitov</dc:creator>
<dc:creator>Akiko Iwasaki</dc:creator>
<dc:date>2024-04-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Exploring new perspectives in immunology</dc:title>
<dc:identifier>pmid:38670066</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.03.038</dc:identifier>
</item>
<item>
<title>Principles and therapeutic applications of adaptive immunity</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38670065/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240428041219&amp;v=2.18.0.post9+e462414
      <description>Adaptive immunity provides protection against infectious and malignant diseases. These effects are mediated by lymphocytes that sense and respond with targeted precision to perturbations induced by pathogens and tissue damage. Here, we review key principles underlying adaptive immunity orchestrated by distinct T cell and B cell populations and their extensions to disease therapies. We discuss the intracellular and intercellular processes shaping antigen specificity and recognition in immune...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Apr 25;187(9):2052-2078. doi: 10.1016/j.cell.2024.03.037.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Adaptive immunity provides protection against infectious and malignant diseases. These effects are mediated by lymphocytes that sense and respond with targeted precision to perturbations induced by pathogens and tissue damage. Here, we review key principles underlying adaptive immunity orchestrated by distinct T cell and B cell populations and their extensions to disease therapies. We discuss the intracellular and intercellular processes shaping antigen specificity and recognition in immune activation and lymphocyte functions in mediating effector and memory responses. We also describe how lymphocytes balance protective immunity against autoimmunity and immunopathology, including during immune tolerance, response to chronic antigen stimulation, and adaptation to non-lymphoid tissues in coordinating tissue immunity and homeostasis. Finally, we discuss extracellular signals and cell-intrinsic programs underpinning adaptive immunity and conclude by summarizing key advances in vaccination and engineering adaptive immune responses for therapeutic interventions. A deeper understanding of these principles holds promise for uncovering new means to improve human health.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38670065/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240428041219&v=2.18.0.post9+e462414">38670065</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.03.037>10.1016/j.cell.2024.03.037</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38670065</guid>
<pubDate>Fri, 26 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Hongbo Chi</dc:creator>
<dc:creator>Marion Pepper</dc:creator>
<dc:creator>Paul G Thomas</dc:creator>
<dc:date>2024-04-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Principles and therapeutic applications of adaptive immunity</dc:title>
<dc:identifier>pmid:38670065</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.03.037</dc:identifier>
</item>
<item>
<title>From periphery to center stage: 50 years of advancements in innate immunity</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38670064/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240428041219&amp;v=2.18.0.post9+e462414
      <description>Over the past 50 years in the field of immunology, something of a Copernican revolution has happened. For a long time, immunologists were mainly concerned with what is termed adaptive immunity, which involves the exquisitely specific activities of lymphocytes. But the other arm of immunity, so-called "innate immunity," had been neglected. To celebrate Cell's 50^(th) anniversary, we have put together a review of the processes and components of innate immunity and trace the seminal contributions...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Apr 25;187(9):2030-2051. doi: 10.1016/j.cell.2024.03.036.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Over the past 50 years in the field of immunology, something of a Copernican revolution has happened. For a long time, immunologists were mainly concerned with what is termed adaptive immunity, which involves the exquisitely specific activities of lymphocytes. But the other arm of immunity, so-called "innate immunity," had been neglected. To celebrate Cell's 50<sup>th</sup> anniversary, we have put together a review of the processes and components of innate immunity and trace the seminal contributions leading to the modern state of this field. Innate immunity has joined adaptive immunity in the center of interest for all those who study the body's defenses, as well as homeostasis and pathology. We are now entering the era where therapeutic targeting of innate immune receptors and downstream signals hold substantial promise for infectious and inflammatory diseases and cancer.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38670064/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240428041219&v=2.18.0.post9+e462414">38670064</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.03.036>10.1016/j.cell.2024.03.036</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38670064</guid>
<pubDate>Fri, 26 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Susan Carpenter</dc:creator>
<dc:creator>Luke A J O'Neill</dc:creator>
<dc:date>2024-04-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>From periphery to center stage: 50 years of advancements in innate immunity</dc:title>
<dc:identifier>pmid:38670064</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.03.036</dc:identifier>
</item>
<item>
<title>Immunology is for everyone</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38670063/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240428041219&amp;v=2.18.0.post9+e462414
      <description>This "Focus on Immunology" issue brings Cell's 50th anniversary celebrations straight to your lymph nodes! Special Leading Edge articles highlight the exciting past, present, and future of the increasingly interdisciplinary field of immunology.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Apr 25;187(9):2029. doi: 10.1016/j.cell.2024.03.044.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">This "Focus on Immunology" issue brings Cell's 50th anniversary celebrations straight to your lymph nodes! Special Leading Edge articles highlight the exciting past, present, and future of the increasingly interdisciplinary field of immunology.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38670063/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240428041219&v=2.18.0.post9+e462414">38670063</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.03.044>10.1016/j.cell.2024.03.044</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38670063</guid>
<pubDate>Fri, 26 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Cell editorial team</dc:creator>
<dc:date>2024-04-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Immunology is for everyone</dc:title>
<dc:identifier>pmid:38670063</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.03.044</dc:identifier>
</item>
<item>
<title>Dissection-like appearance of focal catheter-induced vasospasm in intracoronary optical coherence tomography</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38669048/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240428041219&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Apr 26:ehae240. doi: 10.1093/eurheartj/ehae240. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38669048/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240428041219&v=2.18.0.post9+e462414">38669048</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae240>10.1093/eurheartj/ehae240</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38669048</guid>
<pubDate>Fri, 26 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Rick Volleberg</dc:creator>
<dc:creator>Peter Damman</dc:creator>
<dc:creator>Niels van Royen</dc:creator>
<dc:date>2024-04-26</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Dissection-like appearance of focal catheter-induced vasospasm in intracoronary optical coherence tomography</dc:title>
<dc:identifier>pmid:38669048</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae240</dc:identifier>
</item>
<item>
<title>NETosis Drives Blood Pressure Elevation and Vascular Dysfunction in Hypertension</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38666386/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240428041219&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: These observations identify a role of NETosis in the pathogenesis of hypertension. Moreover, they define an important role of EC stretch and TRPV4 as initiators of NETosis. Finally, they define a role of citrullinated histones as drivers of EC dysfunction in hypertension.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Apr 26. doi: 10.1161/CIRCRESAHA.123.323897. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Neutrophil extracellular traps (NETs) are composed of nDNA, enzymes, and citrullinated histones that are expelled by neutrophils in the process of NETosis. NETs accumulate in the aorta and kidneys in hypertension. PAD4 (protein-arginine deiminase-4) is a calcium-dependent enzyme that is essential for NETosis. TRPV4 (transient receptor potential cation channel subfamily V member 4) is a mechanosensitive calcium channel expressed in neutrophils. Thus, we hypothesize that NETosis contributes to hypertension via NET-mediated endothelial cell (EC) dysfunction.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: NETosis-deficient <i>Padi4</i><sup><i>-/-</i></sup> mice were treated with Ang II (angiotensin II). Blood pressure was measured by radiotelemetry, and vascular reactivity was measured with wire myography. Neutrophils were cultured with or without ECs and exposed to normotensive or hypertensive uniaxial stretch. NETosis was measured by flow cytometry. ECs were treated with citrullinated histone H3, and gene expression was measured by quantitative RT-PCR. Aortic rings were incubated with citrullinated histone H3, and wire myography was performed to evaluate EC function. Neutrophils were treated with the TRPV4 agonist GSK1016790A. Calcium influx was measured using Fluo-4 dye, and NETosis was measured by immunofluorescence.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: <i>Padi4</i><sup><i>-/-</i></sup> mice exhibited attenuated hypertension in response to Ang II, reduced aortic inflammation, and improved EC-dependent vascular relaxation. Coculture of neutrophils with ECs and exposure to hypertensive uniaxial stretch increased NETosis and accumulation of neutrophil citrullinated histone H3. Histone H3 and citrullinated histone H3 exposure attenuates EC-dependent vascular relaxation. Treatment of neutrophils with the TRPV4 agonist GSK1016790A increases intracellular calcium and NETosis.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: These observations identify a role of NETosis in the pathogenesis of hypertension. Moreover, they define an important role of EC stretch and TRPV4 as initiators of NETosis. Finally, they define a role of citrullinated histones as drivers of EC dysfunction in hypertension.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38666386/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240428041219&v=2.18.0.post9+e462414">38666386</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.323897>10.1161/CIRCRESAHA.123.323897</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38666386</guid>
<pubDate>Fri, 26 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Jaya Krishnan</dc:creator>
<dc:creator>Elizabeth M Hennen</dc:creator>
<dc:creator>Mingfang Ao</dc:creator>
<dc:creator>Annet Kirabo</dc:creator>
<dc:creator>Taseer Ahmad</dc:creator>
<dc:creator>Néstor de la Visitación</dc:creator>
<dc:creator>David M Patrick</dc:creator>
<dc:date>2024-04-26</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>NETosis Drives Blood Pressure Elevation and Vascular Dysfunction in Hypertension</dc:title>
<dc:identifier>pmid:38666386</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.323897</dc:identifier>
</item>
<item>
<title>Regeneration of Nonhuman Primate Hearts With Human Induced Pluripotent Stem Cell-Derived Cardiac Spheroids</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38666382/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240428041219&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: We demonstrated that direct injection of hiPSC-CSs restores the contractile functions of injured primate hearts with an acceptable risk of posttransplant arrhythmia. Although the mechanism for the functional benefits is not fully elucidated, these findings provide a strong rationale for conducting clinical trials using the equivalent CM products.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 26. doi: 10.1161/CIRCULATIONAHA.123.064876. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: The clinical application of human induced pluripotent stem cell-derived cardiomyocytes (CMs) for cardiac repair commenced with the epicardial delivery of engineered cardiac tissue; however, the feasibility of the direct delivery of human induced pluripotent stem cell-derived CMs into the cardiac muscle layer, which has reportedly induced electrical integration, is unclear because of concerns about poor engraftment of CMs and posttransplant arrhythmias. Thus, in this study, we prepared purified human induced pluripotent stem cell-derived cardiac spheroids (hiPSC-CSs) and investigated whether their direct injection could regenerate infarcted nonhuman primate hearts.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: We performed 2 separate experiments to explore the appropriate number of human induced pluripotent stem cell-derived CMs. In the first experiment, 10 cynomolgus monkeys were subjected to myocardial infarction 2 weeks before transplantation and were designated as recipients of hiPSC-CSs containing 2×10<sup>7</sup> CMs or the vehicle. The animals were euthanized 12 weeks after transplantation for histological analysis, and cardiac function and arrhythmia were monitored during the observational period. In the second study, we repeated the equivalent transplantation study using more CMs (6×10<sup>7</sup> CMs).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Recipients of hiPSC-CSs containing 2×10<sup>7</sup> CMs showed limited CM grafts and transient increases in fractional shortening compared with those of the vehicle (fractional shortening at 4 weeks after transplantation: 26.2±2.1%; 19.3±1.8%; <i>P</i>&lt;0.05), with a low incidence of posttransplant arrhythmia. Transplantation of increased dose of CMs resulted in significantly greater engraftment and long-term contractile benefits (fractional shortening at 12 weeks after transplantation: 22.5±1.0%; 16.6±1.1%; <i>P</i>&lt;0.01, left ventricular ejection fraction at 12 weeks after transplantation: 49.0±1.4%; 36.3±2.9%; <i>P</i>&lt;0.01). The incidence of posttransplant arrhythmia slightly increased in recipients of hiPSC-CSs containing 6×10<sup>7</sup> CMs.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: We demonstrated that direct injection of hiPSC-CSs restores the contractile functions of injured primate hearts with an acceptable risk of posttransplant arrhythmia. Although the mechanism for the functional benefits is not fully elucidated, these findings provide a strong rationale for conducting clinical trials using the equivalent CM products.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38666382/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240428041219&v=2.18.0.post9+e462414">38666382</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064876>10.1161/CIRCULATIONAHA.123.064876</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38666382</guid>
<pubDate>Fri, 26 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Hideki Kobayashi</dc:creator>
<dc:creator>Shugo Tohyama</dc:creator>
<dc:creator>Hajime Ichimura</dc:creator>
<dc:creator>Noburo Ohashi</dc:creator>
<dc:creator>Shuji Chino</dc:creator>
<dc:creator>Yusuke Soma</dc:creator>
<dc:creator>Hidenori Tani</dc:creator>
<dc:creator>Yuki Tanaka</dc:creator>
<dc:creator>Xiao Yang</dc:creator>
<dc:creator>Naoko Shiba</dc:creator>
<dc:creator>Shin Kadota</dc:creator>
<dc:creator>Kotaro Haga</dc:creator>
<dc:creator>Taijun Moriwaki</dc:creator>
<dc:creator>Yuika Morita-Umei</dc:creator>
<dc:creator>Tomohiko C Umei</dc:creator>
<dc:creator>Otoya Sekine</dc:creator>
<dc:creator>Yoshikazu Kishino</dc:creator>
<dc:creator>Hideaki Kanazawa</dc:creator>
<dc:creator>Hiroyuki Kawagishi</dc:creator>
<dc:creator>Mitsuhiko Yamada</dc:creator>
<dc:creator>Kazumasa Narita</dc:creator>
<dc:creator>Takafumi Naito</dc:creator>
<dc:creator>Tatsuichiro Seto</dc:creator>
<dc:creator>Koichiro Kuwahara</dc:creator>
<dc:creator>Yuji Shiba</dc:creator>
<dc:creator>Keiichi Fukuda</dc:creator>
<dc:date>2024-04-26</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Regeneration of Nonhuman Primate Hearts With Human Induced Pluripotent Stem Cell-Derived Cardiac Spheroids</dc:title>
<dc:identifier>pmid:38666382</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.064876</dc:identifier>
</item>
<item>
<title>Aspirin hypersensitivity: a practical guide for cardiologists</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38666370/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240428041219&amp;v=2.18.0.post9+e462414
      <description>Aspirin has been known for a long time and currently stays as a cornerstone of antithrombotic therapy in cardiovascular disease. In patients with either acute or chronic coronary syndromes undergoing percutaneous coronary intervention aspirin is mandatory in a dual antiplatelet therapy regimen for prevention of stent thrombosis and/or new ischaemic events. Aspirin is also currently a first-option antithrombotic therapy after an aortic prosthetic valve replacement and is occasionally required in...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Apr 26:ehae128. doi: 10.1093/eurheartj/ehae128. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Aspirin has been known for a long time and currently stays as a cornerstone of antithrombotic therapy in cardiovascular disease. In patients with either acute or chronic coronary syndromes undergoing percutaneous coronary intervention aspirin is mandatory in a dual antiplatelet therapy regimen for prevention of stent thrombosis and/or new ischaemic events. Aspirin is also currently a first-option antithrombotic therapy after an aortic prosthetic valve replacement and is occasionally required in addition to oral anticoagulants after implantation of a mechanical valve. Presumed or demonstrated aspirin hypersensitivity is a main clinical problem, limiting the use of a life-saving medication. In the general population, aspirin hypersensitivity has a prevalence of 0.6%-2.5% and has a plethora of clinical presentations, ranging from aspirin-exacerbated respiratory disease to anaphylaxis. Although infrequent, when encountered in clinical practice aspirin hypersensitivity poses for cardiologists a clinical dilemma, which should never be trivialized, avoiding-as much as possible-omission of the drug. We here review the epidemiology of aspirin hypersensitivity, provide an outline of pathophysiological mechanisms and clinical presentations, and review management options, starting from a characterization of true aspirin allergy-in contrast to intolerance-to suggestion of desensitization protocols.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38666370/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240428041219&v=2.18.0.post9+e462414">38666370</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae128>10.1093/eurheartj/ehae128</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38666370</guid>
<pubDate>Fri, 26 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Silvia Grimaldi</dc:creator>
<dc:creator>Paola Migliorini</dc:creator>
<dc:creator>Ilaria Puxeddu</dc:creator>
<dc:creator>Roberta Rossini</dc:creator>
<dc:creator>Raffaele De Caterina</dc:creator>
<dc:date>2024-04-26</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Aspirin hypersensitivity: a practical guide for cardiologists</dc:title>
<dc:identifier>pmid:38666370</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae128</dc:identifier>
</item>
<item>
<title>Income variability and incident cardiovascular disease in diabetes: a population-based cohort study</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38666368/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240428041219&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Higher income variability, income declines, and sustained low income were associated with increased CVD risk. Our findings highlight the need to better understand the mechanisms by which income dynamics impact CVD risk among individuals with T2D.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Apr 26:ehae132. doi: 10.1093/eurheartj/ehae132. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: Longitudinal change in income is crucial in explaining cardiovascular health inequalities. However, there is limited evidence for cardiovascular disease (CVD) risk associated with income dynamics over time among individuals with type 2 diabetes (T2D).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Using a nationally representative sample from the Korean National Health Insurance Service database, 1 528 108 adults aged 30-64 with T2D and no history of CVD were included from 2009 to 2012 (mean follow-up of 7.3 years). Using monthly health insurance premium information, income levels were assessed annually for the baseline year and the four preceding years. Income variability was defined as the intraindividual standard deviation of the percent change in income over 5 years. The primary outcome was a composite event of incident fatal and nonfatal CVD (myocardial infarction, heart failure, and stroke) using insurance claims. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated after adjusting for potential confounders.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: High-income variability was associated with increased CVD risk (HRhighest vs. lowest quartile 1.25, 95% CI 1.22-1.27; Ptrend &lt; .001). Individuals who experienced an income decline (4 years ago vs. baseline) had increased CVD risk, which was particularly notable when the income decreased to the lowest level (i.e. Medical Aid beneficiaries), regardless of their initial income status. Sustained low income (i.e. lowest income quartile) over 5 years was associated with increased CVD risk (HRn = 5 years vs. n = 0 years 1.38, 95% CI 1.35-1.41; Ptrend &lt; .0001), whereas sustained high income (i.e. highest income quartile) was associated with decreased CVD risk (HRn = 5 years vs. n = 0 years 0.71, 95% CI 0.70-0.72; Ptrend &lt; .0001). Sensitivity analyses, exploring potential mediators, such as lifestyle-related factors and obesity, supported the main results.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Higher income variability, income declines, and sustained low income were associated with increased CVD risk. Our findings highlight the need to better understand the mechanisms by which income dynamics impact CVD risk among individuals with T2D.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38666368/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240428041219&v=2.18.0.post9+e462414">38666368</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae132>10.1093/eurheartj/ehae132</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38666368</guid>
<pubDate>Fri, 26 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Yong-Moon Mark Park</dc:creator>
<dc:creator>Jong-Ha Baek</dc:creator>
<dc:creator>Hong Seok Lee</dc:creator>
<dc:creator>Tali Elfassy</dc:creator>
<dc:creator>Clare C Brown</dc:creator>
<dc:creator>Mario Schootman</dc:creator>
<dc:creator>Marie-Rachelle Narcisse</dc:creator>
<dc:creator>Seung-Hyun Ko</dc:creator>
<dc:creator>Pearl A McElfish</dc:creator>
<dc:creator>Michael R Thomsen</dc:creator>
<dc:creator>Benjamin C Amick</dc:creator>
<dc:creator>Seong-Su Lee</dc:creator>
<dc:creator>Kyungdo Han</dc:creator>
<dc:date>2024-04-26</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Income variability and incident cardiovascular disease in diabetes: a population-based cohort study</dc:title>
<dc:identifier>pmid:38666368</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae132</dc:identifier>
</item>
<item>
<title>Insights into the influence of income variability on cardiovascular risk in non-elderly adults with type 2 diabetes</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38666364/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240428041219&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Apr 26:ehae163. doi: 10.1093/eurheartj/ehae163. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38666364/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240428041219&v=2.18.0.post9+e462414">38666364</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae163>10.1093/eurheartj/ehae163</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38666364</guid>
<pubDate>Fri, 26 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Ketrell McWhorter</dc:creator>
<dc:date>2024-04-26</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Insights into the influence of income variability on cardiovascular risk in non-elderly adults with type 2 diabetes</dc:title>
<dc:identifier>pmid:38666364</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae163</dc:identifier>
</item>
<item>
<title>Repurposing of an antiasthmatic drug may reduce NETosis and myocardial ischaemia/reperfusion injury</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38666350/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240428041219&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Apr 26:ehae201. doi: 10.1093/eurheartj/ehae201. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38666350/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240428041219&v=2.18.0.post9+e462414">38666350</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae201>10.1093/eurheartj/ehae201</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38666350</guid>
<pubDate>Fri, 26 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Michael Amponsah-Offeh</dc:creator>
<dc:creator>Simon Tual-Chalot</dc:creator>
<dc:creator>Konstantinos Stellos</dc:creator>
<dc:date>2024-04-26</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Repurposing of an antiasthmatic drug may reduce NETosis and myocardial ischaemia/reperfusion injury</dc:title>
<dc:identifier>pmid:38666350</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae201</dc:identifier>
</item>
<item>
<title>Transcatheter aortic valve replacement: benchmarking practices to optimize quality and outcomes</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38666349/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240428041219&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Apr 26:ehae174. doi: 10.1093/eurheartj/ehae174. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38666349/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240428041219&v=2.18.0.post9+e462414">38666349</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae174>10.1093/eurheartj/ehae174</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38666349</guid>
<pubDate>Fri, 26 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Philippe Pibarot</dc:creator>
<dc:date>2024-04-26</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Transcatheter aortic valve replacement: benchmarking practices to optimize quality and outcomes</dc:title>
<dc:identifier>pmid:38666349</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae174</dc:identifier>
</item>
<item>
<title>Myocardial reperfusion injury exacerbation due to ALDH2 deficiency is mediated by neutrophil extracellular traps and prevented by leukotriene C4 inhibition</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38666340/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240428041219&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: ALDH2 deficiency exacerbates myocardial I/RI by promoting NETosis via the endoplasmic reticulum stress/microsomal glutathione S-transferase 2/LTC4/NOX2 pathway. This study hints at the role of NETosis in the pathogenesis of myocardial I/RI, and pranlukast might be a potential therapeutic option for attenuating I/RI, particularly in individuals with the ALDH2 mutation.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Apr 26:ehae205. doi: 10.1093/eurheartj/ehae205. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: The Glu504Lys polymorphism in the aldehyde dehydrogenase 2 (ALDH2) gene is closely associated with myocardial ischaemia/reperfusion injury (I/RI). The effects of ALDH2 on neutrophil extracellular trap (NET) formation (i.e. NETosis) during I/RI remain unknown. This study aimed to investigate the role of ALDH2 in NETosis in the pathogenesis of myocardial I/RI.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: The mouse model of myocardial I/RI was constructed on wild-type, ALDH2 knockout, peptidylarginine deiminase 4 (Pad4) knockout, and ALDH2/PAD4 double knockout mice. Overall, 308 ST-elevation myocardial infarction patients after primary percutaneous coronary intervention were enrolled in the study.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Enhanced NETosis was observed in human neutrophils carrying the ALDH2 genetic mutation and ischaemic myocardium of ALDH2 knockout mice compared with controls. PAD4 knockout or treatment with NETosis-targeting drugs (GSK484, DNase1) substantially attenuated the extent of myocardial damage, particularly in ALDH2 knockout. Mechanistically, ALDH2 deficiency increased damage-associated molecular pattern release and susceptibility to NET-induced damage during myocardial I/RI. ALDH2 deficiency induced NOX2-dependent NETosis via upregulating the endoplasmic reticulum stress/microsomal glutathione S-transferase 2/leukotriene C4 (LTC4) pathway. The Food and Drug Administration-approved LTC4 receptor antagonist pranlukast ameliorated I/RI by inhibiting NETosis in both wild-type and ALDH2 knockout mice. Serum myeloperoxidase-DNA complex and LTC4 levels exhibited the predictive effect on adverse left ventricular remodelling at 6 months after primary percutaneous coronary intervention in ST-elevation myocardial infarction patients.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: ALDH2 deficiency exacerbates myocardial I/RI by promoting NETosis via the endoplasmic reticulum stress/microsomal glutathione S-transferase 2/LTC4/NOX2 pathway. This study hints at the role of NETosis in the pathogenesis of myocardial I/RI, and pranlukast might be a potential therapeutic option for attenuating I/RI, particularly in individuals with the ALDH2 mutation.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38666340/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240428041219&v=2.18.0.post9+e462414">38666340</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae205>10.1093/eurheartj/ehae205</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38666340</guid>
<pubDate>Fri, 26 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Kun Yang</dc:creator>
<dc:creator>Rifeng Gao</dc:creator>
<dc:creator>Hanchuan Chen</dc:creator>
<dc:creator>Jingjing Hu</dc:creator>
<dc:creator>Peng Zhang</dc:creator>
<dc:creator>Xiang Wei</dc:creator>
<dc:creator>Jiaran Shi</dc:creator>
<dc:creator>Yinyin Chen</dc:creator>
<dc:creator>Liwei Zhang</dc:creator>
<dc:creator>Juntao Chen</dc:creator>
<dc:creator>Yang Lyu</dc:creator>
<dc:creator>Zhen Dong</dc:creator>
<dc:creator>Wei Wei</dc:creator>
<dc:creator>Kai Hu</dc:creator>
<dc:creator>Yansong Guo</dc:creator>
<dc:creator>Junbo Ge</dc:creator>
<dc:creator>Aijun Sun</dc:creator>
<dc:date>2024-04-26</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Myocardial reperfusion injury exacerbation due to ALDH2 deficiency is mediated by neutrophil extracellular traps and prevented by leukotriene C4 inhibition</dc:title>
<dc:identifier>pmid:38666340</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae205</dc:identifier>
</item>





























</channel>
</rss>